Solensky Gerald JR 4
4 · Zomedica Pharmaceuticals Corp. · Filed Jan 14, 2019
Insider Transaction Report
Form 4
Solensky Gerald JR
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2019-01-10+2,100,000→ 2,100,000 totalExercise: $1.52From: 2019-01-10Exp: 2021-01-10→ Common Shares, without par value (2,100,000 underlying)
Footnotes (1)
- [F1]The options vested upon grant. The option is currently fully vested.